<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04100499</url>
  </required_header>
  <id_info>
    <org_study_id>187/19</org_study_id>
    <nct_id>NCT04100499</nct_id>
  </id_info>
  <brief_title>Evaluation of Adjunctive EndoAnchors for EVAR and TEVAR</brief_title>
  <official_title>Evaluation of Adjunctive Use of EndoAnchors During of After EVAR and TEVAR</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital Universitario Ramon y Cajal</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital Universitario Ramon y Cajal</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      EndoAnchors (Heli-FX device, Medtronic, Santa Rosa) have beed described to improve fixation
      (mimicking an open surgical anastomosis) during or after EVAR/TEVAR.

      The investigators want to describe the outcomes of all consecutive patients treated with this
      device (retrospective and prospective data - observational study)
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      EndoAnchors (Heli-FX device, Medtronic, Santa Rosa) have beed designed to improve the
      Endovascular aortic repair. This device is described to mimic an open surgical anastomosis
      during or after EVAR/TEVAR.

      The investigators want to describe the outcomes of all consecutive patients treated with this
      device (retrospective and prospective data - observational study), these outcomes will be
      described in terms of type IA Endoleaks, migration and sac regression.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 19, 2019</start_date>
  <completion_date type="Anticipated">November 19, 2022</completion_date>
  <primary_completion_date type="Anticipated">October 19, 2019</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <target_duration>36 Months</target_duration>
  <primary_outcome>
    <measure>Rate of participants with type IA Endoleaks</measure>
    <time_frame>Three years</time_frame>
    <description>Absence of type IA Endoleaks during follow-up</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Rate of participants with Endograft Migration</measure>
    <time_frame>Three years</time_frame>
    <description>Analysis of Endograft migration during follow-up</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of participants with Sac regression</measure>
    <time_frame>Three years</time_frame>
    <description>Analysis of Sac regression during follow-up</description>
  </secondary_outcome>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Aortic Aneurysm</condition>
  <condition>Thoracic Aortic Aneurysm</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>ESAR (Endosutured Aneurysm Repair)</intervention_name>
    <description>EndoAnchors adjunctive therapy for EVAR and TEVAR</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with abdominal or thoracic aneurysms.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All consecutive patients with adjunctive use of EndoAnchors during or after EVAR and
             TEVAR

        Exclusion Criteria:

          -  Patients that don't want te receive any repair for their disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Andres Reyes Valdivia, Consultant</last_name>
    <role>Principal Investigator</role>
    <affiliation>Vascular Surgery Department</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Andres Reyes Valdivia, Consultant</last_name>
    <phone>+34629586239</phone>
    <email>cauzaza@hotmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Vascular Surgery Department</name>
      <address>
        <city>Madrid</city>
        <zip>28034</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andrés Reyes, Consultant</last_name>
      <phone>+34629586239</phone>
      <email>cauzaza@hotmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>September 2019</verification_date>
  <study_first_submitted>September 19, 2019</study_first_submitted>
  <study_first_submitted_qc>September 20, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">September 24, 2019</study_first_posted>
  <last_update_submitted>September 20, 2019</last_update_submitted>
  <last_update_submitted_qc>September 20, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">September 24, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hospital Universitario Ramon y Cajal</investigator_affiliation>
    <investigator_full_name>Andrés Reyes Valdivia</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Endoanchors</keyword>
  <keyword>EVAR</keyword>
  <keyword>TEVAR</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aneurysm</mesh_term>
    <mesh_term>Aortic Aneurysm</mesh_term>
    <mesh_term>Aortic Aneurysm, Thoracic</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

